Cefixime InnFarm

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefixime InnFarm

Property Description
Active ingredient Cefixime
Form Oral dosage forms (Tablet, Capsule, Suspension)
Pharmacological class beta-Lactam antibiotic, Third-generation cephalosporin
General Purpose Bacterial cell destruction (Bactericidal action)
Origin Synthetic/Semisynthetic

What Type of Medicine is Cefixime InnFarm and How is it Classified?

Cefixime InnFarm is a prescription-only medicine (POM) defined as a potent synthetic antibiotic used to combat infections caused by susceptible bacteria. The core active ingredient is Cefixime, which is chemically classified as a third-generation cephalosporin. The pharmaceutical entity, manufactured by InnFarm, provides a standardized source for this crucial antimicrobial agent.

This drug is a broad-spectrum agent, placing it within the larger family of beta-Lactam antibiotics. This classification is clinically recognized for its enhanced stability against certain bacterial defense mechanisms compared to some earlier-generation analogues. Its fundamental therapeutic purpose is to reliably combat a diverse range of bacterial pathogens, making it a common choice in general practice.

Composition, Origin, and Available Forms

The Cefixime InnFarm preparation is a single-ingredient product, containing only the active compound Cefixime alongside necessary pharmaceutical excipients. Cefixime is a synthetic compound, ensuring a consistent and predictable molecular structure.

Cefixime InnFarm is supplied for the oral route of administration and is available in distinct oral dosage forms, including the tablet, capsule, and oral suspension (liquid) formats. The formulation as an oral suspension is often developed for patient groups who require the active ingredient in an easy-to-swallow liquid form, differentiating it from products available only as solid pills.

The General Purpose of this Bactericidal Agent

The core function of Cefixime InnFarm stems from its defining physiological action as a bactericidal agent. This means the medicine is designed to directly kill the target bacteria, rather than merely halting their growth.

This action is achieved through the inhibition of bacterial cell wall synthesis, which interferes with the organism’s structural integrity. This robust mechanism of effect provides the overall benefit of rapid and effective reduction of the bacterial population, which is essential for the successful resolution of a typical bacterial infection.

Regulatory References

  1. Cephalosporins (NIH StatPearls)
  2. Beta-Lactam Antibiotics (NIH StatPearls)

What side effects are possible with Cefixime InnFarm?

Possible side effects and safety information

The safety profile of Cefixime InnFarm details possible adverse reactions across several System-Organ Classes (SOCs), classified by frequency according to regulatory standards. The most frequently observed reactions affect the Gastrointestinal System, while less common events involve the Nervous, Dermatological, and Hematological Systems.

Frequency-Classified Adverse Reactions

Classification Representative Adverse Reactions
Most Common Diarrhea, Loose Stools
Common Nausea, Abdominal Pain, Vomiting, Headache, Rash
Rare/Very Rare Seizures, Acute Renal Failure, Anaphylaxis, SJS/TEN, Haemolytic Anaemia

Serious Adverse Reactions

Regulatory documentation mandates specific attention to several rare but severe adverse events. These include life-threatening Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as severe immune reactions like Anaphylaxis and hematological disorders like Haemolytic Anaemia. Serious gastrointestinal events like Clostridioides difficile-Associated Diarrhea (CDAD) are also documented, with reported onset times that may be delayed, occurring even after treatment cessation.

Population-Specific Safety Considerations

The official label notes that patients with pre-existing Renal Impairment are at increased risk of serious neurological events, including seizures and encephalopathy, if appropriate dosage reduction is not implemented. Caution is also defined for individuals with a history of Penicillin Allergy due to the documented risk of cross-hypersensitivity. Furthermore, concurrent use with Warfarin is associated with a risk of increased prothrombin time.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents for Cefixime provide specific descriptions of manifestations associated with taking amounts higher than recommended. These documented effects involve the Central Nervous System (CNS), with the potential for a severe reaction classified as encephalopathy. The specific signs that may be observed in such cases include convulsions (seizures), confusion, impairment of consciousness, and movement disorders.

Any suspected overdose event or the observation of these severe neurological signs mandates that the individual seek immediate medical attention or contact emergency services without any delay, as this is an officially required emergency action.

Overdose Consideration Regulatory Statement
Specific Risk Factor The risk of severe neurological effects is explicitly documented as higher in patients with pre-existing renal impairment.
Antidote Availability Official prescribing information confirms that no specific antidote exists for Cefixime overdose.
Supportive Management Management involves providing general supportive measures and may include procedural steps such as considering gastric lavage.
Dialysis Efficacy The drug is not removed in significant quantities from the body via hemodialysis or peritoneal dialysis.

The documented overdose profile strictly defines the required immediate actions and highlights the specific potential for serious CNS outcomes, particularly in patient groups with compromised kidney function.

Therapeutic Uses of Cefixime InnFarm

What Cefixime InnFarm Treats: Main Uses and Benefits

Cefixime InnFarm is commonly used across conditions presenting with acute symptomatic episodes caused by susceptible bacteria. The clinical application involves common therapeutic approaches used to help address groups of symptoms that may appear suddenly and create noticeable interference with functional stability.


Therapeutic Scope and Symptom Relief

The medication is relevant in clinical settings involving heightened patient distress from infections, including acute otitis media, bacterial pharyngitis (strep throat) and tonsillitis, uncomplicated urinary tract infections (UTIs), and acute exacerbations of chronic bronchitis. It is applied to address these conditions when the symptoms create noticeable physiological strain.

The primary benefit is to offer symptomatic relief that helps patients cope more steadily with difficult episodes like painful urination (dysuria), intense ear pain, or pronounced sore throat. The application supports general well-being by easing the overall symptom load of accompanying systemic indicators like fever and malaise.

Quick Fact: Relief for Acute Discomfort
Cefixime is generally applied when short-term symptomatic assistance is needed for infections affecting the ENT, airways, or urinary system.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Cefixime InnFarm? — Official Regulatory Information

Cefixime InnFarm eligibility is defined by official regulatory documentation regarding hypersensitivity, age, and organ function. Use is only permitted for patient groups established in the approved labeling.

Category Official Eligibility Status
Populations for whom use is contraindicated Individuals with a known allergy to Cefixime or to any other cephalosporin antibiotic. Patients with a previous, immediate, and severe allergy to penicillin are also contraindicated due to the risk of cross-hypersensitivity.
Age-related eligibility rules Approved for Adults and Pediatric patients six months of age and older. Safety and efficacy have not been established in infants less than six months of age.
Condition-specific eligibility rules Renal Impairment: Use is permitted, but dose adjustment is required for adult patients with significant kidney dysfunction.
Pregnancy and lactation eligibility status Pregnancy: Should be used only if clearly needed. Lactation: Consideration should be given to discontinuing nursing temporarily during treatment.

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording
Eligibility severity classification Contraindicated (Allergy); Not Established (Infants < 6 months); Conditional Use (Renal Impairment, Pregnancy).
Regulatory basis Based on official governmental prescribing information (e.g., FDA and EMA/SmPC sections).

Connection to the overall eligibility profile

Official regulatory documents define non-eligibility through absolute contraindications related to specific allergies. Use is restricted by minimum age thresholds and physiological constraints. For instance, use in infants is classified as not established, and patients with significant kidney dysfunction require conditional use as a formal dose adjustment is necessary to manage the medicine’s removal from the body.

What should I know about interactions with other medicines?

Cefixime InnFarm Interactions with other medicines and products

It is important to inform your healthcare provider about all medicines you are taking, including prescription and non-prescription drugs, as well as vitamins and herbal supplements, before starting treatment with Cefixime InnFarm. This medicine may interact with several other drugs, potentially affecting their efficacy or increasing the risk of adverse effects.


Notable Drug Interactions

Interacting Medicine Group Potential Interaction Clinical Management
Anticoagulants (e.g., Warfarin) Cefixime may increase the effect of anticoagulants, potentially leading to an increased risk of bleeding. Cephalosporin antibiotics may be associated with reduced prothrombin activity. Close monitoring of coagulation tests, such as the International Normalized Ratio (INR), is essential. The anticoagulant dose may need adjustment.
Probenecid Probenecid can increase the blood levels of Cefixime by reducing its elimination by the kidneys. This combination may be used intentionally to achieve higher antibiotic concentrations, but requires close monitoring for increased side effects.
Nifedipine Nifedipine, a calcium channel blocker, may increase the absorption of Cefixime from the gut, potentially leading to higher blood concentrations of the antibiotic. The healthcare provider should be aware of this combination and monitor the patient appropriately.

Other Important Interactions

  • Live Vaccines (e.g., BCG, Typhoid): Cefixime, as an antibacterial, can decrease the therapeutic efficacy of certain live bacterial vaccines. Consult your doctor before receiving vaccines while on Cefixime InnFarm.
  • Laboratory Tests: Cefixime can cause false-positive results for ketones in urine tests using the nitroprusside method and can also cause a false-positive direct Coombs' test.

Mechanism of Action

Cefixime InnFarm functions as an irreversible inhibitor of Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for cell wall construction. The drug's molecule forms a permanent covalent bond with the active site of these PBPs, specifically disrupting the crucial peptidoglycan cross-linking process required to build the rigid cell wall.

This molecular inactivation causes an immediate structural flaw, leaving the bacterial cell vulnerable to its own internal forces. Because the defective cell wall cannot counteract the naturally high osmotic pressure, the cell rapidly takes on water, leading to its explosive rupture, or lysis. This process provides the drug with its definitive bactericidal physiological effect, which reduces the viability of the bacterial population.

Cefixime's specific chemistry provides it with stability against hydrolysis by many common bacterial defense enzymes known as beta-lactamases. This structural resilience allows the active drug to reach and permanently bind to the PBP targets, thereby allowing the mechanism to be completed.

Dosage and Administration Information

Instruction Map: How to Use Cefixime InnFarm — Official Administration Guidelines

This section outlines the non-instructional, high-level principles for using Cefixime, based strictly on official prescribing information.


Administration Scope

Property Official Instruction
Route of Administration The approved route is oral (ingestion).
Dosing Schedule (Adults) The standard total daily dose is 400 mg. This may be given once daily or as two 200 mg doses every 12 hours.
Timing in relation to meals Tablets and capsules may be taken without regard to food (with or without a meal).
Preparation Requirements The oral suspension requires reconstitution with water and must be shaken well prior to each use.
Age-group administration rules For children 6 months and older, the dose is 8 mg/kg/day, administered once daily or divided into two doses.
Missed-dose rules If a dose is missed, it is taken as soon as remembered. If it is almost time for the next scheduled dose, the missed dose is skipped to continue the regular schedule.
Special procedural conditions For adult patients with severe renal impairment (creatinine clearance < 20 mL/min), the maximum dose is 200 mg once daily.

Resulting Procedural Structure

Official step sequence:

  • The administration route is consistently oral, available in various forms (tablet, capsule, suspension).
  • The standard adult daily dose is 400 mg, often administered as a single daily dose, establishing a typical once-daily frequency pattern.
  • Treatment duration is defined by the official course length, typically 7 to 14 days, with a minimum of 10 days required for infections caused by Streptococcus pyogenes.
  • The liquid form must undergo reconstitution and shaking, and the tablet form should not be substituted for the suspension when treating otitis media in pediatric patients, per documented constraints.

Connection to the overall use protocol: The official instructions establish a time-bound oral administration protocol that permits two main frequency patterns (once or twice daily) for the standard adult dose. They mandate specific procedural steps for the liquid form and define necessary dose reductions for patients with poor kidney function. This structured approach outlines the exact intake conditions, required duration, and administration constraints.

Recent Clinical Evidence

Research evidence / Overview of studies for Cefixime InnFarm

Evidence for Use in Uncomplicated Urinary Tract Infections (UTIs)

Research has explored Cefixime's role in conditions characterized by acute or disruptive episodes, such as uncomplicated urinary tract infections. Studies conducted during periods of increased symptom activity include comparative clinical trials and systematic reviews. These studies monitored outcomes related to functional imbalance, measuring both the resolution of physical discomfort and the bacteriological eradication of the organisms causing the infection.

Findings describe patterns observed in these studies, where researchers reported rates of both clinical outcomes (symptom resolution) and microbiological outcomes (achieving a sterile urine culture). What remains uncertain is the drug’s performance against certain multi-drug resistant bacterial strains, where data are still emerging.


Evidence for Use in Acute Otitis Media (AOM) in Children

Evidence for Cefixime in AOM, a condition associated with acute or disruptive episodes, was evaluated primarily through Randomized Controlled Trials (RCTs) and multicenter comparative trials. These studies focused on pediatric populations and monitored clinical responses (documented as cure or improvement) and the rates at which bacteria were eradicated from the site of infection.

Research also described the patterns of bacteriologic eradication when Cefixime was observed in comparison to comparator antibiotics. The findings are sometimes limited because the study criteria focused specifically on AOM with effusion, meaning the results apply only to the populations studied.


Long-Term Studies and Follow-up Durability

The research for Cefixime primarily involves short-term or intermediate follow-up periods that focus on immediate study outcomes. This evidence contributes to understanding short-term symptom patterns and monitoring immediate bacteriological measurements.

However, long-term effects are not fully established across all indications. There is limited information for long-term outcomes, particularly regarding the durability of the response and the extended interval between infectious episodes.

Key Studies & References

  1. CEFIXIME - FDA Verification Portal (Indications, Dosage, Safety/Efficacy Overview)

Frequently Asked Questions (FAQ)

Common questions about Cefixime InnFarm (FAQ)

Q: How quickly does Cefixime InnFarm start working after taking it?

Official pharmacokinetic studies describe how the medicine is processed by the body. These reports indicate that the highest concentration of Cefixime in the blood is typically reached between 2 to 6 hours after the oral dose is taken. This peak concentration relates to the maximum systemic availability of the active substance.


Q: Is Cefixime InnFarm considered a strong or a weak antibiotic?

Cefixime is officially classified as a third-generation cephalosporin antibiotic. This classification places it within a group of medicines that are recognized for their activity against a diverse range of susceptible bacteria, as documented in official drug classification systems.


Q: What kind of infections does Cefixime InnFarm not work against?

As an antibacterial agent, official product information states that Cefixime is inactive against viral infections, which includes conditions like the common cold or influenza. Official product information notes its lack of effect against certain bacteria, such as most strains of Staphylococcus aureus.


Q: Are there different brand names for the medicine Cefixime?

Yes, Cefixime is the name of the active drug ingredient. Official regulatory and drug information sources confirm that this ingredient is marketed under various brand names globally, in addition to being supplied as a generic medicine.


Q: What is the difference between Cefixime InnFarm and Amoxicillin?

Cefixime is chemically classified as a third-generation cephalosporin antibiotic. Amoxicillin, while also an antibiotic, belongs to a separate class known as penicillin-type antibiotics. Although both are beta-lactam antibiotics, their specific chemical structures and regulatory classifications differ.


Q: Is Cefixime InnFarm the same type of medicine as penicillin?

No, Cefixime is classified as a cephalosporin, which is a distinct category from the penicillin class of antibiotics. However, official regulatory documents note that patients with a known severe allergy to penicillin are advised to proceed with caution due to the documented risk of cross-hypersensitivity reactions.


Q: Does Cefixime InnFarm cause sleepiness or drowsiness?

Official reports on adverse reactions sometimes list general central nervous system side effects, such as dizziness or headache. However, drowsiness or sleepiness is not generally described as one of the common or most frequently reported side effects associated with Cefixime use in the regulatory summaries.


Q: Can Cefixime InnFarm affect the effectiveness of birth control pills?

Official drug labeling warns that Cefixime may potentially reduce the effectiveness of certain birth control pills that contain estrogen. Regulatory information suggests discussing the use of an alternative or supplementary method of birth control while undergoing treatment.


Q: Are there any specific vitamins or supplements that interact with Cefixime InnFarm?

Official instructions consistently advise patients to disclose all medicines and supplements to their prescribing healthcare professional. While the labels detail interactions with other prescription medicines, they typically do not highlight specific common vitamins or herbal supplements as having major defined interactions with Cefixime.


Q: What happens if I forget to take a dose of Cefixime InnFarm?

If a dose is missed, regulatory guidance states that it should generally be taken as soon as it is remembered. However, if it is almost time for the next scheduled intake, the regulatory guidance states that the missed dose should be skipped to return to the regular schedule.


Q: Can I drink alcohol while taking Cefixime InnFarm?

The official labeling for Cefixime does not list a known direct chemical interaction with alcohol. However, since common side effects of the medicine include gastrointestinal upset, alcohol consumption has the potential to intensify common gastrointestinal side effects such as nausea or vomiting.


Q: Does Cefixime InnFarm affect the results of any common medical lab tests?

Yes, official regulatory documents warn that Cefixime can interfere with certain tests. Specifically, it may cause a false-positive result for ketones in urine (using a specific testing method) and for the direct Coombs' test.


Q: How is Cefixime InnFarm eliminated from the body?

Pharmacokinetic data confirms that the medicine is primarily removed from the body through the kidneys (renal excretion). This physiological mechanism is the basis for the regulatory requirement to adjust the dose in patients who have known or significant kidney dysfunction.


Q: What should I do if my symptoms get worse while on Cefixime InnFarm?

Official prescribing information states that the lack of improvement or a worsening of symptoms could indicate the infection is not being adequately treated. If this occurs, the information states that consulting with the prescribing healthcare professional is required to evaluate the course of treatment.


Q: Why is Cefixime InnFarm not usually the first-choice antibiotic for all infections?

Regulatory guidance emphasizes that the use of antibiotics like Cefixime should be limited to infections proven or strongly suspected to be bacterial. Its use is based on its specific indications and local resistance patterns, reflecting its intended role as defined by official guidelines for specific bacterial types and resistance patterns.


Q: Can Cefixime InnFarm be crushed or mixed into food?

Official instructions state that the solid forms (tablets and capsules) may be taken with or without food. Official labeling does not contain instructions regarding crushing the solid forms or mixing them into foods; the liquid suspension requires specific mixing with water.


Q: What are the regulatory guidelines regarding the use of Cefixime InnFarm in specific patient groups?

Official regulatory documents define specific requirements for several populations. This includes a mandatory dose adjustment for adult patients with significant kidney impairment, and specific safety statements defined for use during pregnancy and lactation.


Q: Are there specific instructions for storing Cefixime InnFarm?

Yes, official information details specific storage requirements. Tablets and capsules must be kept at controlled room temperature, and the reconstituted liquid suspension must be discarded after 14 days, regardless of where it is stored.


Q: Does Cefixime InnFarm interact with any common blood thinners?

Official warnings state that Cefixime can increase the effect of certain anticoagulants, specifically citing Warfarin, which raises the potential risk of bleeding. Close monitoring of coagulation tests (blood clotting time) is therefore required when these medicines are used together.


Q: Is Cefixime InnFarm effective against H. pylori?

Official prescribing documents list the approved indications for Cefixime, such as certain respiratory and urinary tract infections. H. pylori is not typically listed as an approved indication for treatment with Cefixime as a single agent in the major regulatory labels.


Q: Why is Cefixime InnFarm available in both tablet and liquid forms?

The medicine is supplied in solid forms (tablet/capsule) and liquid (suspension) to accommodate different patient administration needs. The liquid suspension is often formulated to ensure ease of swallowing, particularly for the pediatric patient population.


Q: What is the general success rate mentioned in studies for Cefixime InnFarm?

Official summaries of clinical trials provide specific rates of clinical success (symptom improvement) and microbiological success (bacterial eradication) for the conditions studied. The rates reflect the documented outcomes observed within the specific patient populations tested.


Q: Does Cefixime InnFarm cause any long-term health issues?

The research evidence for Cefixime, as summarized in regulatory documents, primarily involves short-term or intermediate follow-up periods focused on immediate study outcomes. Consequently, there is limited information within the regulatory labels defining long-term health outcomes across all indications.


Q: Are allergic reactions to Cefixime InnFarm common?

The frequency of allergic reactions varies by severity. Official documentation classifies serious reactions like Anaphylaxis as rare or very rare. However, a less severe generalized rash is officially listed as a common adverse reaction.


Q: Is it common for people to experience a change in appetite while taking Cefixime InnFarm?

Yes, official adverse reaction reports and regulatory documents list a decrease or loss of appetite as a reported side effect of the medicine.


Q: Are there specific types of food to avoid when taking Cefixime InnFarm?

The official instructions for taking the tablets and capsules state they may be taken without regard to food. This means there is no specific regulatory requirement to avoid any particular food or drink when taking the solid dosage forms.


Q: Can Cefixime InnFarm cause temporary changes in gut flora?

Yes, official warnings note that treatment with antibacterial agents like Cefixime can alter the normal bacterial balance (flora) in the colon. This change is the mechanism that can potentially lead to the overgrowth of certain organisms, such as Clostridioides difficile.

How should Cefixime InnFarm be stored and disposed of?

Official Storage and Disposal Requirements

All storage and disposal statements are based strictly on governmental regulatory documentation.

Dosage Form Required Storage Conditions Stability/Disposal Constraint
Tablets/Capsules Store at Controlled Room Temperature (20 C to 25 C), protected from excess heat, moisture, and light. Must be kept in the original, tightly closed container.
Dry Powder Store at Controlled Room Temperature (20 C to 25 C) before mixing. Keep in the original container.
Reconstituted Suspension Store at room temperature or under refrigeration (up to 25 C). Must be discarded after 14 days from the date of mixing.

Child-Safety and Waste: The medicine must be kept out of the sight and reach of children regardless of its form. Any unused or expired Cefixime InnFarm should be disposed of in accordance with local pharmaceutical waste regulations, rather than being placed in household waste or flushed, unless specifically instructed otherwise by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefixime InnFarm found in:

A-Z Index: